SCHEMBL6139420

SCHEMBL6139420

CCCN(CCC)C(=O)c1cc(C(=O)O)cc(-c2ccc(S(=O)(=O)N(C)C)cc2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.49
CA9 Q16790 3/20 0.49
CA12 O43570 2/20 0.49
CA2 P00918 2/20 0.49
RAB9A P51151 1/20 0.49
SLC22A6 Q4U2R8 1/20 0.49
SLC22A8 Q8TCC7 1/20 0.49
ABCC2 Q92887 1/20 0.49
SLC22A12 Q96S37 1/20 0.49
UGT1A7 Q9HAW7 1/20 0.49
SLC22A11 Q9NSA0 1/20 0.49
ALOX5 P09917 3/20 0.45
PTGES O14684 2/20 0.43
GABRA1 P14867 1/20 0.42
GABRB2 P47870 1/20 0.42
TAS2R14 Q9NYV8 1/20 0.39
LIMK1 P53667 1/20 0.39
AKR1B1 P15121 1/20 0.39
GPR55 Q9Y2T6 1/20 0.38
ALDH1A1 P00352 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6139649 0.87 MEN1 (0.45) SMN1; SMN2CA9CA12CA2GABRA1
SCHEMBL3354904 0.85 CA12 (0.41) SMN1; SMN2CA9CA12CA2RAB9A
SCHEMBL6139869 0.82 TP53 (0.51) SMN1; SMN2GABRA1GABRB2ALDH1A1GAA
SCHEMBL3354900 0.81 SMN1; SMN2 (0.41) SMN1; SMN2CA9CA12CA2RAB9A
SCHEMBL3350034 0.79 HPGD (0.55) SMN1; SMN2CA2RAB9AGABRA1GABRB2
SCHEMBL3642059 0.75 CA12 (0.59) SMN1; SMN2CA9CA12CA2RAB9A
SCHEMBL27613909 0.75 CA2 (0.48) SMN1; SMN2CA9CA12CA2RAB9A
SCHEMBL3351273 0.73 P2RY14 (0.47) GABRA1GABRB2HPGDMLYCD
SCHEMBL7608105 0.73 CYP1A2 (0.46) SMN1; SMN2CA9CA12CA2RAB9A
SCHEMBL2953707 0.72 TPMT (0.53) SMN1; SMN2GABRA1GABRB2HPGDMLYCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1503980-A2 SUBSTITUTED HYDROXYETHYLAMINES Elan Pharmaceuticals, Inc. (US) 2005-02-09 EP disclosed
EP-1453789-A2 N,N'-SUBSTITUTED-1,3-DIAMINO-2-HYDROXYPROPANE DERIVATIVES Elan Pharmaceuticals, Inc. (US) 2004-09-08 EP disclosed
WO-2003072535-A2 SUBSTITUTED HYDROXYETHYLAMINES ELAN PHARMACEUTICALS, INC. (US) 2003-09-04 WO disclosed
WO-2003040096-A2 N, N'-SUBSTITUTED-1,3-DIAMINO-2-HYDROXYPROPANE DERIVATIVES ELAN PHARMACEUTICALS, INC. (US) 2003-05-15 WO disclosed